DANIEL COHEN

Allopathic & Osteopathic Physicians|Internal Medicine LEE, MA NPI 1285692129

General Payments — all program years on this page

$3,226.36

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 186
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $467.51 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $467.5122

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $320.7520
2019 $326.3623
2020 $357.8326
2021 $380.9222
2022 $534.7426
2023 $838.2547
2024 $467.5122

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097412267 Novo Nordisk Inc $13.92 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097792242 Novo Nordisk Inc $23.70 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104527868 AstraZeneca Pharmaceuticals LP $14.40 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104558532 AstraZeneca Pharmaceuticals LP $24.98 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104732715 AstraZeneca Pharmaceuticals LP $31.00 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105604195 AstraZeneca Pharmaceuticals LP $23.79 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114618825 Exact Sciences Corporation $18.61 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114618829 Exact Sciences Corporation $20.81 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116737330 GlaxoSmithKline, LLC. $15.39 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118877764 Otsuka America Pharmaceutical, Inc. $25.55 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131285873 PFIZER INC. $15.07 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131408140 PFIZER INC. $16.50 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131781338 PFIZER INC. $20.93 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136116132 Lilly USA, LLC $14.88 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136130428 Lilly USA, LLC $21.70 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145906081 Lundbeck LLC $34.99 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145906083 Lundbeck LLC $6.82 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145906085 Lundbeck LLC $27.24 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145906087 Lundbeck LLC $29.96 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145906089 Lundbeck LLC $13.25 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145906091 Lundbeck LLC $25.68 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148839276 Sumitomo Pharma America, Inc. $28.34 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.